ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly EBT Margin of 45761.31% for Q1 2018, down 36.61% quarter-over-quarter from 33498.39% in Q4 2017.

ENDRA Life Sciences (NDRA) EBT Margin (2016 - 2018) Analysis & Trends

ENDRA Life Sciences (NDRA) has reported EBT Margin for 3 consecutive years, with 45761.31% the latest figure, recorded in Q1 2018.

In Q1 2018, EBT Margin changed N/A year-over-year to 45761.31%; the TTM figure through Dec 2018 stood at 158669.6% (down 15714041.0% YoY), while the FY2018 annual figure was 158669.6%, down 15714041.0% from the prior year.
EBT Margin slipped to 45761.31% in Q1 2018 per NDRA's latest filing, from 33498.39% in the prior quarter.
Across five years, EBT Margin topped out at 133.61% in Q4 2016 and bottomed at 45761.31% in Q1 2018.
Historically, EBT Margin has averaged 16437.67% across 3 years, with a median of 2478.35% in 2017.
On a YoY basis, EBT Margin climbed as much as 3336478 bps in 2017 and fell as far as 3336478 bps in 2017.
ENDRA Life Sciences' EBT Margin stood at 133.61% in 2016, then plunged by 24971 bps to 33498.39% in 2017, then plunged by 37 bps to 45761.31% in 2018.
Business Quant data shows NDRA's EBT Margin at 45761.31% in Q1 2018, 33498.39% in Q4 2017, and 316.69% in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBT Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	16.04%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	17.21%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	34.29%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	22.23%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	6.89%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.17%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	22.43%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	28.17%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	13.54%
10	ENDRA Life Sciences	5.44 Mn	5.08 Mn	-	-

Download Data